WS #11707
AstraZeneca's Wainua misses primary endpoint in late-stage trial, stock falls 9%.
AstraZeneca Heart Drug Trial Failure
AstraZeneca's Wainua misses primary endpoint in late-stage trial, stock falls 9%.
AstraZeneca's Wainua misses primary endpoint in late-stage trial, stock falls 9%.
AstraZeneca's Wainua misses primary endpoint in late-stage trial, stock falls 9%.